Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 378
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2548PCNAProteinHumanUpregulated in HCC than non-HCC (avg ratio HCC to non-tumor 9.1 +/- 5.4) DiagnosticHCC v/s non-tumor p < 0.05Tissue15759316
2549Stathmin 1ProteinHumanUpregulated in HCC than non-HCC (avg ratio HCC to non-tumor 11.1 +/- 15.7) DiagnosticHCC v/s non-tumor p < 0.05Tissue15759316
2550FGGProteinHumanUpregulated in well-differentiated HCC (with 2 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue15852300
2551Isocitrate dehydrogenase [NADP] (cytoplasmic), Fumarate hydratase (mitochondrial), Enoyl-CoA hydratase (mitochondrial), Betaine-homocysteine S-methyltransferase, Serotransferrin precursorProteinHumanDownregulated in well-differentiated HCC (with 2 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue15852300
2552Aldo-keto reductase family 1 member B10, Alpha-1-antitrypsin precursorProteinHumanUpregulated in poorly-differentiated HCC (with 2 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue15852300
2553Keratin type I cytoskeletal 10, Catalase, Aldehyde dehydrogenase (mitochondrial), GlutathioneS-transferase A1, Antioxidant protein 2, Isocitrate dehydrogenase [NADP] (cytoplasmic), Formiminotransferase-cyclodeaminase, Carbonic anhydrase I, Fructose bisphosphate aldolase B, Arginase 1, Fructose-1, 6-ProteinHumanDownregulated in poorly-differentiated HCC (with 2 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue15852300
2554sterol-C5-desaturase, Peroxisomal phytanoyl-CoA alpha-hydroxylase, Homo sapiens clone 23915, Osteopontin 5/6 0, Full-length cDNA clone ZD66D02, Senescence-associated epithelial membrane protein(SEMP1), Human DNA topoisomerase II (top2) mRNA, Homo sapiens lysosomal membrane glycoprotein-2 (LAMP2), HuRNAsHumanUpregulated in HCC than non-tumor DiagnosticTumor v/s normal NATissue12136251
2555KIAA0959 protein, thymosin beta 4 Y isoform(TB4Y)mRNA, Pig7 (PIG7) mRNA, Fas binding protein (hDaxx), putative lung tumor suppressor(DAL1) mRNA complete cds, novel chemokine family member with altered, mRNA for Src-like adapter protein, OSF-1, Hu lambda-17 lambda-like protein (IGLL2), helix-loop-helRNAsHumanDownregulated in HCC than non-tumor DiagnosticTumor v/s normal NATissue12136251
2561HSP70ProteinHumanUpregulated in early HCC components Diagnostic and prognosticnodule-in-nodule-type HCCs and corresponding noncancerous liver tissues p< .001Tissue12500205
2562galectin-3,serine/threonine kinase, translation factor eIF- 4A, -4B, -3, fibroblast growth factor receptor, and ri- bosomal protein L35ARNAsHumanUpregulated in HCC DiagnosticHCC v/s non-tumor Tissue12521301
2563Nip3, decorin, and the insulin-like growth factor binding protein-3RNAsHumanDownregulated in HCC DiagnosticHCC v/s non-tumor Tissue12521301
2564EFNA1Protein and RNAsHumanUpregulated in HCC Diagnostic and PrognosticHCC v/s non-tumor/normal; associated with the poor survival of patients p< 0.001Tissue and Seum19642143
2565EphA2Protein and RNAsHumanDownregulated in HCC Diagnostic and PrognosticHCC v/s non-tumor/normal; associated with the poor survival of patients p < 0.05Tissue and Seum19642143
2566Matrixmetalloproteinase14 or MMP14, MT-MMP1,osteonectin/SPARCRNAsHumanUpregulated in all three tested HCC samples. Diagnostic HCC v/s non-tumor p < 0.05Tissue11813304
2567Cu/Zn-SODRNAsHumanDownregulated in all three tested HCC samples. Diagnostic HCC v/s non-tumor p < 0.07Tissue11813304
2569H19 and IGF2RNAsHumanUpregulated in B-type HCC DiagnosticHBV-HCC vs HCV -HCC; associated with the progression of HCC p < 0.05Tissue12124323
2570MAP2K4, MAP2K5, SF1, SIAHBP1, and MYOGRNAsHumanUpregulated in B-type HCC DiagnosticHBV-HCC vs HCV -HCC; associated with the progression of HCC P< 0.05Tissue12124323
2571MMP9 and VEGFRNAsHumanUpregulated in B-type HCC DiagnosticHBV-HCC vs HCV -HCC; associated with the progression of HCC P< 0.05Tissue12124323
2572MT1E, MT1H, ADH1B, ADH4, CYP2A7, andCYPIIERNAsHumanUpregulated in C-type HCC DiagnosticHBV-HCC vs HCV -HCC; associated with the progression of HCC P< 0.05Tissue12124323
2573BMP4, FLNB, GNG11, GFR, and PTPRKRNAsHumanUpregulated in HBV-HCCs from patients with LC DiagnosticHBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) P< 0.05Tissue12771952
2574NFIB,GFI1,TAF1,ONECUT1,BTF,andTRIM32RNAsHumanUpregulated in HBV-HCCs from patients with LC DiagnosticHBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) P< 0.05Tissue12771952
2575APOC1, APOC2, andAPOC3RNAsHumanUpregulated in HBV-HCCs from patients with LC DiagnosticHBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) P< 0.05Tissue12771952
2576IGF2RNAsHumanUpregulated in HBV-HCCs from patients with LC DiagnosticHBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) P< 0.05Tissue12771952
2577PHBRNAsHumanDownregulated in HBV-HCCs from patients with LC DiagnosticHBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) P< 0.05Tissue12771952
2578IGFBP3RNAsHumanDownregulated in HBV-HCCs from patients with LC DiagnosticHBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) P< 0.05Tissue12771952
2579HSPA1BRNAsHumanDownregulated in HBV-HCCs from patients with LC than HBV-HCCs without LC DiagnosticHBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) P< 0.05Tissue12771952
2588NM23-H2,MCM7, PARP1, YWHAH, HSPB1, MSH2RNAsHumanUpregulated in tumor DiagnosticHCC v/s non-tumor P<0.001Tissue16703398
2589MT1A, MT3RNAsHumandownregulated in tumor DiagnosticHCC v/s non-tumor P<0.001Tissue16703398

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top